TrialAmerican journal of physiology. Endocrinology and metabolism2022

FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes.

Ricardo J Samms et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.